Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients

American Journal of Transplantation - Tập 21 - Trang 2727-2739 - 2021
David Cucchiari1,2, Natalia Egri3, Marta Bodro4, Sabina Herrera4, Jimena Del Risco-Zevallos1, Joaquim Casals-Urquiza1, Frederic Cofan1, Asunción Moreno4, Jordi Rovira2,5, Elisenda Banon-Maneus2,5, Maria J. Ramirez-Bajo2,5, Pedro Ventura-Aguiar1,2, Anna Pérez-Olmos1, Marta Garcia-Pascual1, Mariona Pascal3,6,7, Anna Vilella8, Antoni Trilla8, José Ríos9,10, Eduard Palou3, Manel Juan3
1Department of Nephrology and Kidney Transplantation, Hospital Clínic, Barcelona, Spain
2Laboratori Experimental de Nefrologia i Trasplantament (LENIT), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
3Department of Immunology, Hospital Clínic, Barcelona, Spain
4Department of Infectious Diseases, Hospital Clínic, Barcelona, Spain
5Red de Investigación Renal (REDINREN), Madrid, Spain
6Immunoal·lergia Clínica Respiratoria i Experimental (IRCE), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
7Red Nacional de Alergia, Asma, Reacciones Adversas y Alérgicas (ARADyAL), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
8Department of Preventive Medicine and Epidemiology, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
9Medical Statistics Core Facility, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
10Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain

Tài liệu tham khảo

World Health Organization. WHO coronavirus dashboard. https://covid19.who.int/. Accessed April 14, 2021. US Department of Health and Human Services. BARDA’s expanding COVID-19 medical countermeasure portfolio. https://www.medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx?filter=vaccine. Accessed April 14, 2021. Walsh, 2020, Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates, N Engl J Med., 383, 2439, 10.1056/NEJMoa2027906 Jackson, 2020, An mRNA vaccine against SARS-CoV-2 — Preliminary report, N Engl J Med., 383, 1920, 10.1056/NEJMoa2022483 Caillard, 2021, Is COVID-19 infection more severe in kidney transplant recipients?, Am J Transplant., 21, 1295, 10.1111/ajt.16424 Manuel, 2011, Humoral response to the influenza a H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients, Clin Infect Dis., 52, 248, 10.1093/cid/ciq104 Birdwell, 2009, decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study, Am J Kidney Dis., 54, 112, 10.1053/j.ajkd.2008.09.023 Cordero, 2017, Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1–2, a randomized controlled clinical trial, Clin Infect Dis., 64, 829, 10.1093/cid/ciw855 Natori, 2018, A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients, Clin Infect Dis., 66, 1698, 10.1093/cid/cix1082 Boyarsky, 2021, Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients, JAMA - J Am Med Assoc., 325, 1784, 10.1001/jama.2021.4385 Jackson, 2020, mRNA-1273 Study Group. An mRNA vaccine against SARS-CoV-2—Preliminary report, N Engl J Med., 383, 1920, 10.1056/NEJMoa2022483 Meneghini, 2018, Combining sensitive crossmatch assays with donor/recipient human leukocyte antigen eplet matching predicts living-donor kidney transplant outcome, Kidney Int Rep., 3, 926, 10.1016/j.ekir.2018.03.015 Montagud-Marrahi, 2020, Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single center cohort of kidney recipients, Am J Transplant., 20, 2058, 10.1111/ajt.15970 Garcia-Basteiro, 2020, Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital, Nat Commun., 11, 3500, 10.1038/s41467-020-17318-x Baden, 2021, Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine, N Engl J Med., 384, 403, 10.1056/NEJMoa2035389 Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-Cov-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant. 2021. https://doi.org/10.1111/ajt.16615 Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021. Published online May 5, 2021. https://doi.org/10.1001/jama.2021.7489 Le Bert, 2020, SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls, Nature., 584, 457, 10.1038/s41586-020-2550-z Babel, 2021, Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient, Am J Transpl., 20, 3210, 10.1111/ajt.16252 Loinaz, 1997, Hepatitis B vaccination results in 140 liver transplant recipients, Hepatogastroenterology., 44, 235 Shalabi, 2019, Outcome of repeated vaccination to Hepatitis B virus in patients failing to respond to vaccination following allogeneic hematopoietic stem cell transplantation (HSCT): If at first you don’t succeed, try try again, Blood., 134, 2012, 10.1182/blood-2019-127336 Healy, 2011, Implementation of cocooning against pertussis in a high-risk population, Clin Inf Dis., 52, 157, 10.1093/cid/ciq001 Schillie, 2012, Immune response of hepatitis B Vaccine among persons with diabetes, Diabetes Care., 35, 2690, 10.2337/dc12-0312 Crepin, 2015, ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients, Am J Transplant., 15, 1028, 10.1111/ajt.13092 Grupper, 2021, Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis, Clin J Am Soc Nephrol., 6